The angiogenesis hypothesis may provide new insights by suggesting a decline in angiogenic growth factors with age, which in turn leads to a reduction in microcirculation in the body (Ambrose 2016)
Sometimes it just needs the right support and resources to do its job effectively
The Drugs@FDA database contains no entry for BPC-157 in any indication, and ClinicalTrials.gov shows no ongoing human studies registered in the United States
Its primary distinction is its dual-pathway mechanism (VEGFR2 + NO) combined with its gastric stability making it the only compound in this group with demonstrated activity when administered orally in animal models, not just by injection
Also, BPC 157 attenuated and improved the postponed deleterious outcome (lower brain edema, significantly lower number and size of haemorrhagic traumatic lacerations, significantly lower intensity of subarachnoidal bleeding, significantly less intraventricular haemorrhage shown microscopically, declined fatality) (19)
10.1080/07853890.2023.2191218 Summary Keywords diabetes, chronic kidney disease, gum acacia, melatonin, betaine, flaxseed Citation Al Zaabi M, Al Suleimani Y, Ali H, Ali BH and Al Maskari R (2025) The effect of different combinations of flaxseed, melatonin, gum acacia, and betaine on diabetic rats with adenine-induced chronic kidney disease
